Carlsmed Appoints New CFO
Carlsmed (NASDAQ:CARL) has appointed Richard Heppenstall as its new chief financial officer, effective immediately. He replaces Leo Greenstein, who is leaving the company. Heppenstall brings extensive experience in healthcare and life sciences finance, having held senior roles at ZimVie, Breg, and Orthofix Medical. The leadership change comes with Carlsmed reaffirming its 2026 revenue outlook, signaling continued confidence in future growth despite the executive transition. The company has not indicated any operational disruptions due to Greenstein's departure or Heppenstall’s appointment at this time.
Topics: CFO Appointment Leadership